1. Home
  2. NUWE vs LEO Comparison

NUWE vs LEO Comparison

Compare NUWE & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUWE
  • LEO
  • Stock Information
  • Founded
  • NUWE 1999
  • LEO 1987
  • Country
  • NUWE United States
  • LEO United States
  • Employees
  • NUWE N/A
  • LEO N/A
  • Industry
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LEO Trusts Except Educational Religious and Charitable
  • Sector
  • NUWE Health Care
  • LEO Finance
  • Exchange
  • NUWE Nasdaq
  • LEO Nasdaq
  • Market Cap
  • NUWE 3.9M
  • LEO 363.8M
  • IPO Year
  • NUWE N/A
  • LEO N/A
  • Fundamental
  • Price
  • NUWE $0.20
  • LEO $5.98
  • Analyst Decision
  • NUWE Strong Buy
  • LEO
  • Analyst Count
  • NUWE 1
  • LEO 0
  • Target Price
  • NUWE $17.00
  • LEO N/A
  • AVG Volume (30 Days)
  • NUWE 31.3M
  • LEO 200.2K
  • Earning Date
  • NUWE 08-12-2025
  • LEO 01-01-0001
  • Dividend Yield
  • NUWE N/A
  • LEO 4.01%
  • EPS Growth
  • NUWE N/A
  • LEO N/A
  • EPS
  • NUWE N/A
  • LEO 0.04
  • Revenue
  • NUWE $8,787,000.00
  • LEO N/A
  • Revenue This Year
  • NUWE $6.53
  • LEO N/A
  • Revenue Next Year
  • NUWE $51.63
  • LEO N/A
  • P/E Ratio
  • NUWE N/A
  • LEO $152.00
  • Revenue Growth
  • NUWE N/A
  • LEO N/A
  • 52 Week Low
  • NUWE $0.19
  • LEO $4.98
  • 52 Week High
  • NUWE $5.84
  • LEO $6.50
  • Technical
  • Relative Strength Index (RSI)
  • NUWE 24.08
  • LEO 66.33
  • Support Level
  • NUWE $0.21
  • LEO $5.77
  • Resistance Level
  • NUWE $0.24
  • LEO $5.96
  • Average True Range (ATR)
  • NUWE 0.03
  • LEO 0.04
  • MACD
  • NUWE 0.01
  • LEO 0.02
  • Stochastic Oscillator
  • NUWE 7.14
  • LEO 100.00

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

About LEO BNY Mellon Strategic Municipals Inc.

BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others. BNY Mellon and its affiliates, including BNYM Investment Adviser, INA and others involved in the management, sales, investment activities, business operations or distribution of the Fund, are engaged in businesses and have interests other than that of managing the Fund.

Share on Social Networks: